These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 30428693)
41. Shifting from inpatient to outpatient treatment of deep vein thrombosis in a tertiary care center: a cost-minimization analysis. Boucher M; Rodger M; Johnson JA; Tierney M Pharmacotherapy; 2003 Mar; 23(3):301-9. PubMed ID: 12627927 [TBL] [Abstract][Full Text] [Related]
42. Anticoagulant therapy for symptomatic calf deep vein thrombosis (CACTUS): a randomised, double-blind, placebo-controlled trial. Righini M; Galanaud JP; Guenneguez H; Brisot D; Diard A; Faisse P; Barrellier MT; Hamel-Desnos C; Jurus C; Pichot O; Martin M; Mazzolai L; Choquenet C; Accassat S; Robert-Ebadi H; Carrier M; Le Gal G; Mermilllod B; Laroche JP; Bounameaux H; Perrier A; Kahn SR; Quere I Lancet Haematol; 2016 Dec; 3(12):e556-e562. PubMed ID: 27836513 [TBL] [Abstract][Full Text] [Related]
43. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L, Ninet J, Duhaut P et al for the Investigators of the 'Durée Optimale du Traitement Antivitamines K' (DOTAVK) study. Circulation 2001; 103: 2453-60. Anand SS Vasc Med; 2001 Nov; 6(4):269-70. PubMed ID: 11958396 [TBL] [Abstract][Full Text] [Related]
44. Tinzaparin in outpatients with pulmonary embolism or deep vein thrombosis. Dager WE; King JH; Branch JM; Chow SL; Ferrer RE; Pak S; Togioka PY; White RH Ann Pharmacother; 2005; 39(7-8):1182-7. PubMed ID: 15956232 [TBL] [Abstract][Full Text] [Related]
45. Outpatient Management in Patients with Venous Thromboembolism with Edoxaban: A Post Hoc Analysis of the Hokusai-VTE Study. Medina A; Raskob G; Ageno W; Cohen AT; Brekelmans MPA; Chen CZ; Grosso MA; Mercuri MF; Segers A; Verhamme P; Vanassche T; Wells PS; Lin M; Winters SM; Weitz JI; Büller HR Thromb Haemost; 2017 Dec; 117(12):2406-2414. PubMed ID: 29212128 [TBL] [Abstract][Full Text] [Related]
46. Patient outcomes and cost analysis associated with an outpatient deep venous thrombosis treatment program. Groce JB Pharmacotherapy; 1998; 18(6 Pt 3):175S-180S. PubMed ID: 9853912 [TBL] [Abstract][Full Text] [Related]
47. Emergency Department Management of Suspected Calf-Vein Deep Venous Thrombosis: A Diagnostic Algorithm. Kitchen L; Lawrence M; Speicher M; Frumkin K West J Emerg Med; 2016 Jul; 17(4):384-90. PubMed ID: 27429688 [TBL] [Abstract][Full Text] [Related]
48. Bed rest versus early ambulation with standard anticoagulation in the management of deep vein thrombosis: a meta-analysis. Liu Z; Tao X; Chen Y; Fan Z; Li Y PLoS One; 2015; 10(4):e0121388. PubMed ID: 25860350 [TBL] [Abstract][Full Text] [Related]
50. Outpatient treatment of venous thromboembolism with low-molecular-weight heparin: an economic evaluation. Huse DM; Cummins G; Taylor DC; Russell MW Am J Manag Care; 2002 Jan; 8(1 Suppl):S10-6. PubMed ID: 11822346 [TBL] [Abstract][Full Text] [Related]
51. Duplex ultrasound, clinical score, thrombotic risk, and D-dimer testing for evidence based diagnosis and management of deep vein thrombosis and alternative diagnoses in the primary care setting and outpatient ward. Michiels JJ; Moosdorff W; Maasland H; Michiels JM; Lao MU; Neumann HA; Dulicek P; Stvrtinova V; Barth J; Palareti G Int Angiol; 2014 Feb; 33(1):1-19. PubMed ID: 24452081 [TBL] [Abstract][Full Text] [Related]
52. Isolated distal deep vein thrombosis: efficacy and safety of a protocol of treatment. Treatment of Isolated Calf Thrombosis (TICT) Study. Parisi R; Visonà A; Camporese G; Verlato F; Lessiani G; Antignani PL; Palareti G Int Angiol; 2009 Feb; 28(1):68-72. PubMed ID: 19190559 [TBL] [Abstract][Full Text] [Related]
54. Statin therapy associated with improved thrombus resolution in patients with deep vein thrombosis. Hsu C; Brahmandam A; Brownson KE; Huynh N; Reynolds J; Lee AI; Fares WH; Ochoa Chaar CI J Vasc Surg Venous Lymphat Disord; 2019 Mar; 7(2):169-175.e4. PubMed ID: 30660579 [TBL] [Abstract][Full Text] [Related]
55. Multicenter Implementation of a Novel Management Protocol Increases the Outpatient Treatment of Pulmonary Embolism and Deep Vein Thrombosis. Kabrhel C; Rosovsky R; Baugh C; Connors J; White B; Giordano N; Torrey J; Deadmon E; Parry BA; Hagan S; Zheng H Acad Emerg Med; 2019 Jun; 26(6):657-669. PubMed ID: 30341928 [TBL] [Abstract][Full Text] [Related]
56. Comparison of 3 and 6 months of oral anticoagulant therapy after a first episode of proximal deep vein thrombosis or pulmonary embolism and comparison of 6 and 12 weeks of therapy after isolated calf deep vein thrombosis. Pinede L; Ninet J; Duhaut P; Chabaud S; Demolombe-Rague S; Durieu I; Nony P; Sanson C; Boissel JP; Circulation; 2001 May; 103(20):2453-60. PubMed ID: 11369685 [TBL] [Abstract][Full Text] [Related]
57. Outpatient management of DVT using low molecular weight heparin and a hospital outreach service. Rymes NL; Lester W; Connor C; Chakrabarti S; Fegan CD Clin Lab Haematol; 2002 Jun; 24(3):165-70. PubMed ID: 12067281 [TBL] [Abstract][Full Text] [Related]
58. Deep vein thrombosis outcome and the level of oral anticoagulation therapy. Caprini JA; Arcelus JI; Reyna JJ; Motykie GD; Mohktee D; Zebala LP; Cohen EB J Vasc Surg; 1999 Nov; 30(5):805-11. PubMed ID: 10550177 [TBL] [Abstract][Full Text] [Related]